TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GKOS

Glaukos Corp

Healthcare · Medical Devices

161.50$ -1.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow GKOS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-15.6% -3.1% 10.8% 16.0% 10.4% -0.2% -10.2% 8.4% -11.7% -18.4% -16.0% -9.1%
9.3% 6.0% 4.1% 3.4% 3.5% 4.2% 15.4% 11.7% 12.7% 12.1% 10.4% 7.5%
3.4% 11.0% 7.7% 11.0% 14.2% 15.4% 20.7% 10.3% 13.6% 13.8% 13.1% 12.5%
-1.0% 12.6% 8.0% 10.3% 15.2% 15.6% 20.3% 11.9% 14.4%
2.7% -4.7% -5.5% 1.7% -2.0% -1.9% -1.4% 1.2% -4.8% -3.2% -10.3% -6.2%
1.9% 1.2% 5.5% 4.0% 5.7% 2.0% 3.1% 16.3% 10.7% 6.4% 1.6% 1.5%
-1.9% -119.4% -22.8% -7.4% -14.6% 18.3% -91.2% -19.8% 15.8% 4.5% 12.5% -15.3%
0.0% 0.0% 0.0% 5.4% 116.7% 9.3% 2.3%
3.6% 4.6% 7.0% 2.9% -0.3% -2.4% -1.7% -1.3% -1.0% -1.0% -1.7%
4.1% -13.7% -8.5% -14.1% -12.4% -9.5% 123.5% -0.2% -0.2% -0.2% -0.4% -0.2%
7.7% 149.4% -1.4% 2.9% 11.9% -4.1% 116.7% 13.4% 2.2% 4.8% 23.9% 2.3%
-9.7% 26.9% -13.2% 11.3% 7.8% 13.8% 15.2% 1.4% 6.7% -8.3% 19.9% -21.9%
-17.5% -4.3% 5.3% 12.1% 4.7% -2.1% -13.3% -7.8% -22.4% -24.8% -17.6% -10.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?